SOFTMEDX (00648) Issues Approximately 16.3 Million Scheme Shares at 96% Discount
Stock News
Mar 10
SOFTMEDX (00648) announced that, due to a continued deterioration of its financial condition since trading was suspended, the company resolved in 2023 to proceed with a debt restructuring via a scheme. In December 2023, the scheme was registered with the Companies Registry and became effective. To fulfill the scheme's requirements, the company must issue 16,301,841 scheme shares to creditors at an issue price of HK$0.01 per share within six months from the resumption of trading. The issue price represents a 96% discount to the closing price of HK$0.28 per share as quoted on the Stock Exchange on the date of this announcement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.